- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/50 - Proteinases
Patent holdings for IPC class C12N 9/50
Total number of patents in this class: 1053
10-year publication summary
57
|
49
|
65
|
97
|
66
|
66
|
66
|
78
|
79
|
54
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3321 |
63 |
The Regents of the University of California | 19943 |
24 |
Allergan, Inc. | 2345 |
16 |
Massachusetts Institute of Technology | 10057 |
14 |
Danisco US Inc. | 1102 |
13 |
University of Washington | 2330 |
13 |
DSM IP Assets B.V. | 5587 |
12 |
Ipsen Bioinnovation Limited | 40 |
12 |
The Board of Trustees of the Leland Stanford Junior University | 6424 |
11 |
President and Fellows of Harvard College | 5973 |
11 |
Codexis, Inc. | 802 |
11 |
California Institute of Technology | 3975 |
10 |
Lysando AG | 47 |
9 |
Sandoz AG | 1418 |
8 |
Endo Biologics Limited | 30 |
8 |
Alcresta Therapeutics, Inc. | 42 |
7 |
Amano Enzyme Inc. | 391 |
7 |
Jiangnan University | 1531 |
7 |
Kao Corporation | 4964 |
6 |
Boehringer Ingelheim RCV GmbH & Co KG | 58 |
6 |
Other owners | 785 |